May 27, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 308
May 29, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 447
Jun 4, 2026 ET · Open — · High — · Low — · Close $0.01 · Volume 19
Jun 12, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 145
Jun 16, 2026 ET · Open — · High — · Low — · Close $0.01 · Volume 10
Jun 24, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 424
Jun 25, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 559
Jun 26, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 275
Jul 9, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 106
Jul 17, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 355
Jul 20, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 4
Aug 5, 2026 ET · Open $0.00 · High $1.50 · Low $0.00 · Close $0.00 · Volume 1,844
Aug 17, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 109
Aug 26, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 1,218
Sep 9, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 346
Sep 11, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 214
Sep 25, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 2,282
Sep 29, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 419
Oct 5, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 194
Oct 6, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 257
Oct 12, 2026 ET · Open $0.07 · High $0.07 · Low $0.07 · Close $0.07 · Volume 833
Oct 16, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 4,129
Nov 10, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 117
Nov 13, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 977
Event records
Event records load after the price chart.
Split-adjusted daily prices · Price as of Nov 17, 2026, 8:49 PM ET
Initial 6M price range summary
Range
6M
First close
$0.00
Last close
$0.00
High
$1.50
Low
$0.00
Volume
15,591
Open
—Historical · Nov 13, 2026
Previous close
—Historical · Nov 13, 2026
Day range
—Historical · Nov 13, 2026
52-week range
—Through Nov 16, 2026
Volume
—Historical · Nov 13, 2026
Average volume (30 calendar days, 3 sessions)
1.74KThrough Nov 16, 2026
Market cap$9.59K
P/E (TTM)negative earnings —
Forward P/E—
EPS (TTM)stale vendor snapshot —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)−1.57
Price history
TRVN · nasdaq · USD
Last completed session: Nov 13, 2026
Split-adjusted · volume in shares
Missing sessions: Nov 2, 2026, Nov 3, 2026, Nov 4, 2026, Nov 5, 2026, Nov 6, 2026, Nov 9, 2026, Nov 11, 2026, Nov 12, 2026, Nov 16, 2026, Nov 17, 2026
November 2026 · 2 completed sessions
Date
Open
High
Low
Close
Change
Volume
0.0005
0.0005
0.0005
0.0005
—
977
Open 0.0005High 0.0005Low 0.0005
0.0004
0.0004
0.0004
0.0004
—
117
Open 0.0004High 0.0004Low 0.0004
Notable price movement
Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.
$0.00+25.00%
Trading volume was 0.5 times the 30-day average, with 977 shares traded.
$0.00−20.00%
Trading volume was 0.0 times the 30-day average, with 117 shares traded.
$0.00−99.24%
Trading volume was 5.2 times the 30-day average, with 4.13K shares traded.
Options flow
— · Options flow not available
Q Score
—/100—
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Not scored: Equity peers
What each one means
LiquidityNot scored
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
ShortNot scored
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
SqueezeNot scored
Higher scores reflect a higher published Squeeze score within equity peers.
TrendNot scored
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
MomentumNot scored
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
ValuationNot scored
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
StabilityNot scored
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic
Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.